Pediatric Respiratory Medicine
With multiple national and international meetings taking place throughout the year, deciding which conferences to attend isn't always straightforward. While scientific programs are an important consideration, opportunities for networking, collaboration, career development and practical learning can be just as valuable. To help identify the meetings making the biggest impact across respiratory and pulmonary medicine and related specialties, we asked members of the touchRESPIRATORY community their non-negotiable conferences and what makes them worth attending.
We are deeply saddened to share the passing of Dr Ronald A Strauss, an esteemed member of the Editorial Board of touchREVIEWS in Respiratory & Pulmonary Diseases, who died on 12 January 2025 at the age of 80 in Cleveland Heights, OH, USA. ...
The GINA 2025 strategy report introduces a more personalised, age-specific, and proactive approach to asthma care. Key updates include the shift away from SABA monotherapy, expanded use of biomarkers for treatment guidance, and increased emphasis on environmental factors like climate change. The guidelines highlight shared decision-making, routine monitoring, and tailored treatment plans, aiming to reduce exacerbations and improve outcomes across all age groups.
As touchRESPIRATORY approaches 10 years of providing education for busy respiratory specialists, we are looking to the future—and it certainly looks bright!
Physician burnout is at a critical point. In this episode, Nicky speaks with Dr Alfred Atanda about why so many physicians are burning out and what can be done to change the trend. From personal experience to system-wide solutions, Dr Atanda shares valuable insights on improving physician well-being and building a more effective healthcare culture.
What if your medical degree could launch more than a clinical career? In this candid and compelling read, Dr Jon Edelson shares his lessons for early-career clinicians ready to think beyond the bedside and explore the business of medicine.
In this episode, we explore the future of continuing medical education (CME) with the team behind touchIME. Hannah Fisher and Matthew Goodwin share insights into global and US trends, the importance of patient inclusivity and how educational outcomes are evolving to better measure the direct impact of learning on clinical practice and patient care.
We are excited to welcome you to San Francisco for the ATS 2025 International Conference! Leaders, as well as emerging scientists and clinicians, who are at the forefront of medical breakthroughs and clinical innovation in pulmonary, critical care and sleep medicine will gather for networking and inspiring talks.
The International Primary Care Respiratory Group (IPCRG), is proud to host the 8th IPCRG Scientific Meeting in Brașov, Romania, on Friday 11 and Saturday 12 April 2025. This event, in partnership with the RespiRO team and the Transilvania University of Brașov promises to bring together researchers, innovators, and industry leaders to advance respiratory care in primary health settings.
Dupilumab is indicated as an add-on maintenance treatment in children aged 6 years and older with asthma, and demonstrated clinical efficacy in the pivotal VOYAGE study (NCT0294895). We caught up with Dr Theresa W Guilbert (Cincinnati Children's Hospital & Medical Center; ...
touchRESPIRATORY were delighted to speak with Dr Theresa W Guilbert (Cincinnati Children's Hospital & Medical Center; University of Cincinnati, Cincinnati, OH, USA) about the health and economic burden of asthma exacerbations in children, and the limitations of current therapeutic options ...
The InPedILD trial was a phase 3, double-blind placebo-controlled trial investigating nintedanib in children and adolescents with fibrosing interstitial lung diseases (ClinicalTrials.gov: NCT04093024). We were delighted to speak to Dr. Robin Deterding (University of Colorado; Children's Hospital Colorado, Aurora, CO, ...
Nintedanib is an inhibitor of tyrosine kinases involved in the progression of pulmonary fibrosis and blocks the signalling pathways involved in fibrotic processes. We were delighted to speak to Dr. Robin Deterding (University of Colorado; Children's Hospital Colorado, Aurora, CO, ...
Log into your Touch Account
Keep track of your clinical interests and newsletter subscriptions.
Sign up with an Email
Or use a .
Register now for FREE access
Already registered? Login below.
